TUCSON, AZ – July 21, 2014 – Azbil BioVigilant, Inc., (www.biovigilant.com), inventors of Instantaneous Microbial Detection™, announced today that the Company has successfully resolved its dispute with TSI concerning TSI’s U.S. patent number 6,831,279.
Last week, TSI filed a notice with the U.S. Patent and Trademark Office, which in effect, will result in the termination of the patent. In addition, TSI and Azbil BioVigilant jointly filed a request to dismiss TSI’s appeal of the U.S. District Court’s ruling where the underlying claims of TSI’s patent were found to be invalid.
“We are pleased to bring this patent litigation to a conclusion. This ends, once and for all, the threat the suit presented to our customers,” said Aric Meares president and CEO of Azbil BioVigilant.
Representing Azbil BioVigilant in its patent litigation was Amster, Rothstein & Ebenstein LLP.
With headquarters in Tucson, Arizona, Azbil BioVigilant invented instantaneous microbial detection technology to address environmental monitoring needs in the pharmaceutical, biotechnology, healthcare, and environmental applications. Azbil BioVigilant’s IMD systems detect – instantaneously and in real-time – particle count, size, and biological status. Unlike other rapid microbial methods, Azbil BioVigilant’s optically-based systems require no staining, no reagents, no waiting period, and little human intervention. The company holds 19 patents with an additional 37 applications pending. Azbil BioVigilant’s parent company is Azbil Corporation of the Azbil Group, part of the TOPIX Mid400 traded on the Tokyo Stock Exchange. For more information, go to www.biovigilant.com.
The Azbil Group consists of Azbil Corporation and its affiliate and subsidiary companies. The Azbil Group has operations in 18 countries worldwide and more than 9,500 employees. For detailed information, visit www.azbil.com.
IMD-A®, IMD-W™, BioVigilant®, the BioVigilant logo, and the term Instantaneous Microbial Detection™ are the trademarks or registered trademarks of Azbil BioVigilant, Inc. in the United States and/or other countries. Other names or brands may be the property of others.
Contact Mary Parsons, BioVigilant Systems, email@example.com, 520-292-2342.